REGESTRONE LX 40MG TABLET (28 TABLETS)

Form: Tablets

Pack Size: 28 TABLETS

Marketed by: TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV)

MRP: ₹2380.00

TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV): Regestrone LX 40MG Tablet (28 Tablets), 28 tablets, salt relugolix 40mg. Its MRP stays at Rs 2,380 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 1,813.33. Group: oral GnRH antagonist (hormone therapy). Same salt is also supplied by La Renon. Handling/counselling: check the strength: 120 mg is the prostate-cancer product. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.